Cargando…
Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan
We identified the major points that are described in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E17 guideline but have not been considered in the past multiregional clinical trials (MRCTs) used for drug approval in Japan to elucidate...
Autores principales: | Asano, Kunihito, Aoi, Yoko, Kamada, Shuji, Uyama, Yoshiaki, Tohkin, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246727/ https://www.ncbi.nlm.nih.gov/pubmed/33245786 http://dx.doi.org/10.1002/cpt.2121 |
Ejemplares similares
-
Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan
por: Asano, Kunihito, et al.
Publicado: (2017) -
Evaluation of Consistency of Treatment Response Across Regions—the LEADER Trial in Relation to the ICH E17 Guideline
por: Nielsen, Henrik K., et al.
Publicado: (2021) -
Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
por: Niazi, Sarfaraz K., et al.
Publicado: (2022) -
„Wenn ich groß bin, geh‘ ich in die Pflege“
por: Jerusalem, Anna, et al.
Publicado: (2022) -
Multiregional Tumor Trees Are Not Phylogenies
por: Alves, João M., et al.
Publicado: (2017)